Skip to main content

Cristina Murray-Krezan, PhD

Associate Professor of Medicine

Additional Positions

  • Associate Professor of Clinical & Translational Science
  • Deputy Director for the Center for Biostatistics and Qualitative Methodology (CBQM)

Meet Dr. Cristina Murray-Krezan

Cristina Murray-Krezan, PhD, joined the Pitt faculty in September 2021 as a Biostatistician and Associate Professor of Medicine and Clinical and Translational Science. With expertise in clinical trials and complex study designs, she is the Deputy Director for the Center for Biostatistics and Qualitative Methodology (CBQM). Her research interests include integrating medical and behavioral treatments for substance use disorders and she has a particular interest in work that aims to promote health equity and accessibility in underserved and marginalized populations. She teaches for and serves as the Clinical Trials Track Director in the Institute for Clinical Research Education.

Dr. Murray-Krezan recently served as Chair of the PCORI Clinical Trials Advisory Panel and is actively involved in the Society for Clinical Trials. Additionally, she is a longtime member of the American Statistical Association and the International Biometric Society, and is a founding member and steering committee member of the UNIversity data COoRdinating CeNters (UNICORN) Network. In 2016, she co-founded the University of New Mexico Statistics and Data Coordinating Center and served as its director from 2016-2021. Prior to her academic career, she was a biostatistician at Emmes in Rockville, MD where she worked in early phase vaccine and treatment trials for malaria and other tropical diseases.

Dr. Murray-Krezan plays the flute and piano and still sometimes dreams of getting a MM in flute performance. She loves gardening and feels like Snow White’s lost sister with all the wildlife in her yard. After running two marathons and several half-marathons in the 2010s, she moved on to hiking and recently earned the rank of Ee Dan (second degree black belt) in taekwondo.

Education & Training
BS, Astrophysics, University of New Mexico, 2001
MS, Statistics, University of Virginia, 2006
PhD, Statistics, University of New Mexico, 2021
Awards
AAMC Mid-Career Women Faculty Leadership Development Seminar attendee, American Association of Medical Colleges
Office of Academic Career Development Advanced Faculty Leadership Academy attendee, University of Pittsburgh
Chair of PCORI Clinical Trials Advisory Panel 2023-2024, and member 2021-2024
Representative Publications

Kawasaki SS, Liebschutz JM, Murray-Krezan C, Switzer GE, Nash S, Jeong K, Winstanley EL. Barriers to Buprenorphine Initiation in Patients Using Fentanyl. JAMA Netw Open. 2026 Jan 2;9(1):e2552136. doi: 10.1001/jamanetworkopen.2025.52136. PMID: 41490107; PMCID: PMC12771233.

Ober AJ, Murray-Krezan C, Page K, Friedmann PD, Anderson J, Osilla KC, Ryzewicz S, Huerta S, Mazer MW, Hoskinson RA, Garvey R, Peltz A, Watkins KE, Nuckols T, IsHak WW, Mariano LT, Danovitch I. Hospital Addiction Consultation Service and Opioid Use Disorder Treatment: The START Randomized Clinical Trial. JAMA Intern Med. 2025 Jun 1;185(6):624-633. doi: 10.1001/jamainternmed.2024.8586. PMID: 40193131; PMCID: PMC11976642.

 

Salay M, Edwards KA, Winstanley EL, Bachrach RL, Bulls HW, Hanmer J, Liebschutz JM, Robbins J, Wilson JD, Yu L, Merlin JS, Murray-Krezan C. Study Protocol for Pain Self-Management and Patient-Oriented Buprenorphine Dosing for Pain and Retention in Office-Based Opioid Treatment: A Hybrid Type 1, 2 × 2 Factorial Randomized Controlled Trial. Subst Use Addctn J. 2025 Jan;46(1):201-207. doi: 10.1177/29767342241261562. Epub 2024 Jun 22. PMID: 38907678; PMCID: PMC11863306.

 

Litwin AH, Lum PJ, Tayler LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Heo M, Arnsten J, Meissner P, Karasz A, Mckee MD, Ward JW, Johnson N, Pericot-Valverde I, Agyemang L, Stein ES, Thomas A, Borsuk C, Blalock KL, Wilkinson S, Wagner K, Roche J, Murray-Krezan C, Anderson J, Jacobsohn V, Luetkemeyer AF, Falade-Nwulia O, Page, K; HERO Study Group. Patient-centred models of hepatitis C treatment for people who inject drugs: A multicentre, pragmatic randomised trial. Lancet Gastroenterol Heptaol. 2020 Dec;7(12):1112-1127.

Research Interests
  • Substance use disorders
  • Statistics and data coordinating centers
  • Clinical trials
  • Methods to adjust for informative dropout